Track topics on Twitter Track topics that are important to you
Alkermes has entered into a definitive agreement to sell its manufacturing facility in Gainesville, GA, the manufacturing and royalty revenue associated with products manufactured at the facility and ...
Recro Pharma has completed the acquisition of assets from Alkermes and its affiliates including worldwide rights to IV/IM meloxicam, and a contract manufacturing facility, royalty and formulation busi...
The US Food and Drug Administration (FDA) has accepted for review Iroko Pharmaceuticals' new drug application (NDA) for SoluMatrix meloxicam, a low dose nonsteroidal anti-inflammatory drug (NSAID), fo...
Recro Pharma Inc. received global rights to Alkermes PLC's meloxicam candidates for pain. The deal also includes the acquisition of Alkermes' Gainesville, Georgia GMP manufacturing plant, along with a...
The Affordable Care Act has done little to reduce the number of Americans who lack dental coverage.
The analgesic and antihyperalgesic effects of dipyrone, meloxicam or a dipyrone-meloxicam combination were compared in dogs undergoing elective ovariohysterectomy. In a double-blinded, prospective, ra...
Cerebral vasospasm considered to be a serious cause of morbidity and mortality following subarachnoid haemorrhage (SAH).Despite several available therapeutic options, current protocols do not prevent ...
The purpose of the present study was to assess the clinical consequences of untreated dental caries related to the occurrence of toothache among Brazilian preschool children.
Data on reptile analgesia are scarce for nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids and almost completely lacking in sea turtles, even though emergencies requiring correct pain manageme...
In this study we evaluated the effects of meloxicam administered at 0.5 mg/kg IM q12h for 14 days on hematologic and plasma biochemical values and on kidney tissue in 11 healthy African grey parrots (...